Sonova Enters Rechargeable In-Ear Hearing Aid Market with Phonak Virto R Infinio

Sonova Holding AG ( (CH:SOON) ) just unveiled an update.

Sonova has launched the Phonak Virto R Infinio, its first rechargeable in-ear hearing aid, marking the company’s entry into this growing market segment. This product, available initially in the USA, combines advanced technology for better speech understanding and connectivity, and represents a significant step in expanding Sonova’s product portfolio to meet diverse customer needs.

The most recent analyst rating on (CH:SOON) stock is a Sell with a CHF224.00 price target. To see the full list of analyst forecasts on Sonova Holding AG stock, see the CH:SOON Stock Forecast page.

More about Sonova Holding AG

Sonova is a world-leading provider of innovative hearing solutions, including personal audio devices, wireless communication solutions, audiological services, hearing aids, and cochlear implants. Founded in 1947 and headquartered in Stäfa, Switzerland, Sonova operates in four business areas: Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants. The company is represented by core brands such as Phonak, Unitron, AudioNova, Sennheiser (under license), and Advanced Bionics, serving customers in over 100 countries with a global distribution network.

Average Trading Volume: 145,921

Technical Sentiment Signal: Sell

Current Market Cap: CHF12.94B

For a thorough assessment of SOON stock, go to TipRanks’ Stock Analysis page.